Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | F7 | P08709 | 2/20 | 0.37 |
| ▸ | F3 | P13726 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25421262 | 0.92 | FAAH (0.45) | ALDH1A1MAPTALOX15HSD17B10FFAR1 | |
| SCHEMBL1311557 | 0.90 | FAAH (0.47) | ALDH1A1MAPTALOX15HSD17B10FFAR1 | |
| SCHEMBL9579092 | 0.90 | FAAH (0.47) | ALDH1A1MAPTALOX15HSD17B10FFAR1 | |
| SCHEMBL2901524 | 0.86 | FAAH (0.50) | ALDH1A1MAPTALOX15HSD17B10LMNA | |
| SCHEMBL13571362 | 0.86 | FAAH (0.50) | ALDH1A1MAPTALOX15HSD17B10LMNA | |
| SCHEMBL8431397 | 0.86 | FAAH (0.50) | ALDH1A1MAPTALOX15HSD17B10LMNA | |
| SCHEMBL9751428 | 0.86 | FAAH (0.50) | ALDH1A1MAPTALOX15HSD17B10LMNA | |
| SCHEMBL1110917 | 0.85 | CNR2 (0.39) | ALDH1A1MAPTFFAR1HPGDFFAR4 | |
| SCHEMBL250711 | 0.85 | ALDH1A1 (0.39) | ALDH1A1MAPTFFAR1HPGDFFAR4 | |
| SCHEMBL15082660 | 0.82 | FAAH (0.47) | ALDH1A1MAPTALOX15HSD17B10FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6797724-B2 | TO ELIMINATE BOOPHILUS MICROPLUS IN CATTLE AND LICE AND BLOWFLY IN SHEEP | MERIAL (FR) | 2004-09-28 | — | — | US | claimed |
| EP-4041186-B1 | AN ANHYDROUS PHARMACEUTICAL COMPOSITION FOR MAINTENANCE TREATMENT OF PSORIASIS | LEO PHARMA AS (DK) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024083558-A1 | EMULSIFIABLE CONCENTRATE (EC) | SYNGENTA CROP PROTECTION AG (CH) | 2024-04-25 | — | — | WO | disclosed |
| US-20230398131-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | LEO PHARMA AS (DK) | 2023-12-14 | — | — | US | disclosed |
| WO-2023104624-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023104626-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-06-15 | — | — | WO | disclosed |
| WO-2023104625-A1 | HERBICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2023-06-15 | — | — | WO | disclosed |
| CN-111479554-B | Cosmetic composition comprising a silicone elastomer and an emollient | 联合利华知识产权控股有限公司 | 2023-02-28 | — | — | CN | disclosed |
| CN-114555055-A | Anhydrous pharmaceutical composition for the maintenance treatment of psoriasis | 利奥制药有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-11253463-B2 | Cosmetic compositions comprising silicone elastomer and emollient | CONOPCO, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| CN-102939078-A | Pharmaceutical spray composition containing vitamin D analogue and corticosteroid | LEO PHARMA AS | 2013-02-20 | — | — | CN | disclosed |
| WO-2012064557-A2 | DEODORIZING COMPOSITIONS | LIPO CHEMICALS INC. (US) | 2012-05-18 | — | — | WO | disclosed |
| WO-2008060878-A2 | ANTIPERSPIRANT DEODORANT COMPOSITIONS | LIPO CHEMICALS INC. (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-0738141-A4 | SUCROSE ESTER C-20 TO C-28 ALCOHOL FORMULATIONS | LIDAK PHARMACEUTICALS (US) | 1998-01-07 | — | — | EP | disclosed |
| US-5672340-A | GEL OR SOLID; INCLUDES A BORATE CROSSLINKER, A NONIONIC SURFACTANT, WATER, AND A HYDROPHOBIC COMPOUND | HELENE CURTIS, INC. (US) | 1997-09-30 | — | — | US | disclosed |
| EP-0738141-A1 | SUCROSE ESTER C-20 TO C-28 ALCOHOL FORMULATIONS | LIDAK PHARMACEUTICALS (US) | 1996-10-23 | — | — | EP | disclosed |
| WO-1995016434-A1 | SUCROSE ESTER C-20 TO C-28 ALCOHOL FORMULATIONS | LIDAK PHARMACEUTICALS (US) | 1995-06-22 | — | — | WO | disclosed |
| EP-0358528-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1994-06-15 | — | — | EP | disclosed |
| US-4981845-A | HYDROXYALKANOIC ACID, POLYETHER, OIL | CHESEBROUGH POND'S U.S.A. CO., DIVISION OF CONOPCO, INC. (US) | 1991-01-01 | — | — | US | disclosed |
| EP-0358528-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1990-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398131-A1 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID | CYP24A1, CYP2R1, VDR | LPAR2 2235/4885LPAR3 1183/4885LPAR1 2242/4885 |
| US-11253463-B2 | Cosmetic compositions comprising silicone elastomer and emollient | DAGLA, EP300, DEGS1 | LPAR2 319/4885LPAR3 237/4885LPAR1 458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.